ARTICLE | Company News
Catabasis Pharmaceuticals, Sarepta Therapeutics deal
October 3, 2016 7:00 AM UTC
The companies partnered to conduct mouse model research to evaluate Duchenne muscular dystrophy (DMD) therapies comprising Sarepta’s exon skipping technology and Exondys 51 eteplirsen analog with Cat...